← FDA DRUG APPROVALS

FDA ANDA · ANDA203907

DONEPEZIL HYDROCHLORIDE

Sponsor: SCIEGEN PHARMS

APPLICATION
ANDA203907
TYPE
ANDA
ORIGINAL APPROVAL
2014-10-29
LATEST ACTION
2020-08-11
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

DONEPEZIL HYDROCHLORIDEPrescription
DONEPEZIL HYDROCHLORIDE 10MG · TABLET · ORAL
DONEPEZIL HYDROCHLORIDEPrescription
DONEPEZIL HYDROCHLORIDE 5MG · TABLET · ORAL

Approval history

2020-08-11Labeling · Supplement 12 · standardAP
2015-12-01Labeling · Supplement 5 · standardAP
2014-10-29UNKNOWN · OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →